U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07097831) titled 'A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects' on July 24.
Brief Summary: The study was designed to evaluate the pharmacokinetic effects of rosuvastatin calcium tablets after oral administration of HRS-1301 in healthy subjects.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Hyperlipidemia
Intervention:
DRUG: HRS-1301 Tablets
HRS-1301 tablets.
DRUG: Rosuvastatin Calcium Tablets
Rosuvastatin calcium tablets.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Disclaimer: Curated by HT Syndication....